(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.
The three biggest winners today are NAI ORD SHARES, SOC FRANC CASINOS, and BIOCARTIS.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| NAI ORD SHARES (NAI.AS) | 9.60 | 7.26% | 2023-08-11 11:03:30 |
| SOC FRANC CASINOS (SFCA.PA) | 1.95 | 7.14% | 2023-08-11 11:03:25 |
| BIOCARTIS (BCART.BR) | 0.35 | 6.77% | 2023-08-11 11:06:24 |
| LAVIDE HOLDING (LVIDE.AS) | 0.25 | 5.93% | 2023-08-11 11:03:14 |
| NEW SOURCES ENERGY (NSE.AS) | 0.05 | 5.88% | 2023-08-11 11:03:37 |
| NHOA (NHOA.PA) | 3.57 | 5% | 2023-08-11 11:00:50 |
| ALAN ALLMAN (AAA.PA) | 12.60 | 5% | 2023-08-11 11:36:22 |
| EXPLOSIFS PROD.CHI (EXPL.PA) | 128.00 | 4.92% | 2023-08-11 11:49:04 |
| NANOBIOTIX (NANO.PA) | 8.31 | 4.79% | 2023-08-11 11:00:37 |
| PHOTOCURE (PHO.OL) | 44.50 | 4.34% | 2023-08-11 11:32:47 |
The three biggest losers today are EURASIA FONC INV, BEAULIEU-AV. CERT, and NAVAMEDIC.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| EURASIA FONC INV (EFI.PA) | 0.30 | -15.64% | 2023-08-11 08:48:29 |
| BEAULIEU-AV. CERT (BEAB.BR) | 4.06 | -9.78% | 2023-08-11 11:06:03 |
| NAVAMEDIC (NAVA.OL) | 34.00 | -8.11% | 2023-08-11 08:31:28 |
| ENVIPCO (ENVI.AS) | 2.26 | -5.83% | 2023-08-11 11:02:07 |
| XILAM ANIMATION (XIL.PA) | 23.80 | -5.18% | 2023-08-11 11:06:04 |
| GC RIEBER SHIPPING (RISH.OL) | 18.85 | -5.04% | 2023-08-11 11:30:08 |
| FOUNTAIN (FOU.BR) | 1.14 | -5% | 2023-08-11 11:07:39 |
| NEXT BIOMETRICS GP (NEXT.OL) | 5.54 | -4.81% | 2023-08-11 11:31:42 |
| DASSAULT AVIATION (AM.PA) | 171.80 | -4.77% | 2023-08-11 11:47:35 |
| PAREF (PAR.PA) | 53.50 | -4.46% | 2023-08-11 11:01:23 |
Winners today
1. NAI ORD SHARES (NAI.AS)
7.26% Price Change
New Amsterdam Invest N.V. focuses on acquiring a stake in company active as an operating company in the real estate sector primarily in Europe and the United States. The company was incorporated in 2021 and is based in Amsterdam, the Netherlands.
AEX-Index ended the session with NAI ORD SHARES rising 7.26% to €9.60 on Friday while AEX-Index fell 1.62% to €765.16.
Earnings Per Share
As for profitability, NAI ORD SHARES has a trailing twelve months EPS of €-0.41.
Volume
Today’s last reported volume for NAI ORD SHARES is 133 which is 74.02% below its average volume of 512.
More news about NAI ORD SHARES.
2. SOC FRANC CASINOS (SFCA.PA)
7.14% Price Change
Société Française de Casinos Société Anonyme operates casinos in France. The company is also involved in the hotel and restaurant activities. The company is based in Paris, France.
CAC 40 ended the session with SOC FRANC CASINOS jumping 7.14% to €1.95 on Friday while CAC 40 dropped 1.26% to €7,340.19.
Earnings Per Share
As for profitability, SOC FRANC CASINOS has a trailing twelve months EPS of €0.33.
PE Ratio
SOC FRANC CASINOS has a trailing twelve months price to earnings ratio of 5.91. Meaning, the purchaser of the share is investing €5.91 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.61%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10.4%, now sitting on 13.26M for the twelve trailing months.
More news about SOC FRANC CASINOS.
3. BIOCARTIS (BCART.BR)
6.77% Price Change
Biocartis Group NV, a molecular diagnostics company, provides diagnostic solutions enhancing clinical practice for the benefit of patients, clinicians, payers, and healthcare industry with a focus on oncology. Its proprietary molecular diagnostics Idylla platform is a real-time polymerase chain reaction system that offers molecular information that allows treatment selection and treatment progress monitoring. The company offers Idylla BRAF, KRAS, MSI, EGFR, and NRAS-BRAF mutation tests; and Idylla SARS-CoV-2/Flu/RSV panels and SARS-CoV-2 tests, as well as SeptiCyte RAPID, a rapid host-response test. It also provides research products, including MSI, KRAS, BRAF, ctEGFR, NRAS-BRAF-EGFR S492R, ctKRAS, EGFR, GeneFusion, ctBRAF, and ctNRAS-BRAF-EGFR S492R mutation assays. The company has a collaboration agreement with Amgen to evaluate Idylla RAS testing as a tool for rapid decentralized testing and/or to accelerate access to RAS biomarker information using Idylla platform and RAS tests; and Bristol-Myers Squibb Company for the registration of diagnostic and use of the Idylla MSI test in connection with immuno-oncology therapies. It also has a license, development, and commercialization agreement with GeneproDx for the development of ThyroidPrint novel genomic test on the Idylla platform; and collaboration with APIS Assay Technologies Ltd. to develop and commercialize breast cancer subtyping test on the Idylla platform. The company was founded in 2007 and is headquartered in Mechelen, Belgium.
BEL 20 ended the session with BIOCARTIS rising 6.77% to €0.35 on Friday while BEL 20 fell 0.91% to €3,684.94.
Earnings Per Share
As for profitability, BIOCARTIS has a trailing twelve months EPS of €-1.1.
Volatility
BIOCARTIS’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.10%, a negative 0.23%, and a positive 2.12%.
BIOCARTIS’s highest amplitude of average volatility was 0.51% (last week), 1.40% (last month), and 2.12% (last quarter).
More news about BIOCARTIS.
4. LAVIDE HOLDING (LVIDE.AS)
5.93% Price Change
Lavide Holding N.V. does not have significant operations. Previously, it was engaged in the provision of integrated information technology solutions for medium to large-sized companies and organizations. The company was formerly known as Qurius N.V. and changed its name to Lavide Holding N.V. in July 2013. Lavide Holding N.V. was incorporated in 1998 and is based in Sluis, the Netherlands.
AEX-Index ended the session with LAVIDE HOLDING rising 5.93% to €0.25 on Friday while AEX-Index slid 1.62% to €765.16.
Earnings Per Share
As for profitability, LAVIDE HOLDING has a trailing twelve months EPS of €-0.04.
More news about LAVIDE HOLDING.
5. NEW SOURCES ENERGY (NSE.AS)
5.88% Price Change
New Sources Energy N.V. develops, operates, exploits, and invests in projects that generates electricity using renewable energy sources. The company was formerly known as Management Share NV and changed its name to New Sources Energy N.V. in July 2011. New Sources Energy N.V. is headquartered in Amersfoort, the Netherlands.
AEX-Index ended the session with NEW SOURCES ENERGY rising 5.88% to €0.05 on Friday while AEX-Index fell 1.62% to €765.16.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -288.52%.
Moving Average
NEW SOURCES ENERGY’s worth is way above its 50-day moving average of €0.02 and higher than its 200-day moving average of €0.05.
Yearly Top and Bottom Value
NEW SOURCES ENERGY’s stock is valued at €0.05 at 22:40 EST, way under its 52-week high of €0.07 and way above its 52-week low of €0.01.
More news about NEW SOURCES ENERGY.
6. NHOA (NHOA.PA)
5% Price Change
NHOA S.A. provides energy storage, E-mobility, and EV fastcharging infrastructure related solutions in France. The company offers solar plus storage, utility-scale storage, and industrial microgrids. It also provides charging services and devices for electric and hybrid vehicles. In addition, the company offers power house, and hybrid house; and HyESS, a technology platform for the transformation of renewables into sustainable grids, as well as Atlante, an eStation that provides fast charging solution. NHOA S.A. is based in Paris, France.
CAC 40 ended the session with NHOA rising 5% to €3.57 on Friday, following the last session’s downward trend. CAC 40 slid 1.26% to €7,340.19, after two consecutive sessions in a row of gains, on what was an all-around bearish trend trading session today.
Earnings Per Share
As for profitability, NHOA has a trailing twelve months EPS of €-1.57.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -58.43%.
More news about NHOA.
7. ALAN ALLMAN (AAA.PA)
5% Price Change
Alan Allman Associates, together with its subsidiaries, engages in the provision of consulting services in Canada, France, Belgium, Luxembourg, Switzerland, and Singapore. The company offers technology consulting in the areas, including cybersecurity, cloud, data management, digitalization of tools and processes, etc.; strategy and management consulting comprising risk management, commercial intelligence, market finance, process management, change management, etc.; and industrial transformation consulting, such as purchasing and supply chain issues, relocation, cost reduction, project management, materials, process consulting, etc. The company was incorporated in 1954 and is based in Issy-les-Moulineaux, France.
CAC 40 ended the session with ALAN ALLMAN jumping 5% to €12.60 on Friday, following the last session’s downward trend. CAC 40 slid 1.26% to €7,340.19, after two successive sessions in a row of gains, on what was an all-around bearish trend trading session today.
Earnings Per Share
As for profitability, ALAN ALLMAN has a trailing twelve months EPS of €0.22.
PE Ratio
ALAN ALLMAN has a trailing twelve months price to earnings ratio of 57.27. Meaning, the purchaser of the share is investing €57.27 for every euro of annual earnings.
Volume
Today’s last reported volume for ALAN ALLMAN is 213 which is 47.27% below its average volume of 404.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jun 28, 2022, the estimated forward annual dividend rate is 0.05 and the estimated forward annual dividend yield is 0.51%.
Yearly Top and Bottom Value
ALAN ALLMAN’s stock is valued at €12.60 at 22:40 EST, way under its 52-week high of €16.10 and way above its 52-week low of €8.50.
Volatility
ALAN ALLMAN’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.53%, a positive 0.02%, and a positive 1.35%.
ALAN ALLMAN’s highest amplitude of average volatility was 1.37% (last week), 0.78% (last month), and 1.35% (last quarter).
More news about ALAN ALLMAN.
8. EXPLOSIFS PROD.CHI (EXPL.PA)
4.92% Price Change
EPC Groupe engages in the manufacture, storage, and distribution of explosives in Europe, Africa, Asia Pacific, and the Americas. The company also provides drilling and mining services; logistics services; and demolition services, including mechanical demolition, deconstruction and blasting of buildings, waste management, and asbestos removal. In addition, it produces 2-ethylhexyl nitrate, a diesel fuel additive that reduces emissions and enhances diesel engine performance. It serves customers operating in the mining, cement, aggregates, civil engineering, and defense industries. EPC Groupe was founded in 1893 and is headquartered in Paris, France. EPC Groupe is a subsidiary of Ste E.J. Barbier.
CAC 40 ended the session with EXPLOSIFS PROD.CHI rising 4.92% to €128.00 on Friday, after four sequential sessions in a row of losses. CAC 40 slid 1.26% to €7,340.19, after two consecutive sessions in a row of gains, on what was an all-around down trend exchanging session today.
Earnings Per Share
As for profitability, EXPLOSIFS PROD.CHI has a trailing twelve months EPS of €4.99.
PE Ratio
EXPLOSIFS PROD.CHI has a trailing twelve months price to earnings ratio of 25.65. Meaning, the purchaser of the share is investing €25.65 for every euro of annual earnings.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EXPLOSIFS PROD.CHI’s stock is considered to be overbought (>=80).
More news about EXPLOSIFS PROD.CHI.
9. NANOBIOTIX (NANO.PA)
4.79% Price Change
Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. Nanobiotix S.A. has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France.
CAC 40 ended the session with NANOBIOTIX jumping 4.79% to €8.31 on Friday, after five sequential sessions in a row of gains. CAC 40 fell 1.26% to €7,340.19, after two successive sessions in a row of gains, on what was an all-around negative trend exchanging session today.
Earnings Per Share
As for profitability, NANOBIOTIX has a trailing twelve months EPS of €-1.82.
Revenue Growth
Year-on-year quarterly revenue growth grew by 159.6%, now sitting on 4.78M for the twelve trailing months.
Moving Average
NANOBIOTIX’s worth is way higher than its 50-day moving average of €5.35 and way above its 200-day moving average of €4.06.
More news about NANOBIOTIX.
10. PHOTOCURE (PHO.OL)
4.34% Price Change
Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the BeNeLux, Italy, other European Countries, Canada, and the United States. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus infection and precancerous lesions of the cervix. The company sells its products to pharmaceutical wholesalers, pharmacies, and hospitals through license partners. Photocure ASA was founded in 1993 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with PHOTOCURE jumping 4.34% to €44.50 on Friday while Oslo Børs Benchmark Index_GI rose 0.43% to €1,260.92.
Earnings Per Share
As for profitability, PHOTOCURE has a trailing twelve months EPS of kr-2.24.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.16%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
PHOTOCURE’s EBITDA is 295.04.
Moving Average
PHOTOCURE’s worth is below its 50-day moving average of kr49.02 and way below its 200-day moving average of kr78.28.
Volatility
PHOTOCURE’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.28%, a negative 0.43%, and a positive 1.63%.
PHOTOCURE’s highest amplitude of average volatility was 2.28% (last week), 1.72% (last month), and 1.63% (last quarter).
Volume
Today’s last reported volume for PHOTOCURE is 354698 which is 409.71% above its average volume of 69587.
More news about PHOTOCURE.
Losers Today
1. EURASIA FONC INV (EFI.PA)
-15.64% Price Change
Eurasia Fonciere Investissements Société Anonyme owns, develops, and manages corporate and commercial real estate assets. The company was formerly known as MB Retail Europe and changed its name to Eurasia Fonciere Investissements Société Anonyme in January 2012. The company was founded in 1984 and is headquartered in Paris, France. Eurasia Fonciere Investissements Société Anonyme is a subsidiary of Eurasia Groupe SA.
CAC 40 ended the session with EURASIA FONC INV dropping 15.64% to €0.30 on Friday, after five successive sessions in a row of losses. CAC 40 slid 1.26% to €7,340.19, after two sequential sessions in a row of gains, on what was an all-around negative trend trading session today.
Yearly Top and Bottom Value
EURASIA FONC INV’s stock is valued at €0.30 at 22:40 EST, way under its 52-week high of €0.45 and way above its 52-week low of €0.26.
Moving Average
EURASIA FONC INV’s worth is below its 50-day moving average of €0.32 and below its 200-day moving average of €0.30.
Volume
Today’s last reported volume for EURASIA FONC INV is 3 which is 94.44% below its average volume of 54.
More news about EURASIA FONC INV.
2. BEAULIEU-AV. CERT (BEAB.BR)
-9.78% Price Change
Immo-Beaulieu NV owns and operates real estate properties. The company is based in Brussels, Belgium. Immo-Beaulieu NV operates as a subsidiary of KBC Bank NV.
BEL 20 ended the session with BEAULIEU-AV. CERT falling 9.78% to €4.06 on Friday while BEL 20 dropped 0.91% to €3,684.94.
Volume
Today’s last reported volume for BEAULIEU-AV. CERT is 20 which is 81.3% below its average volume of 107.
More news about BEAULIEU-AV. CERT.
3. NAVAMEDIC (NAVA.OL)
-8.11% Price Change
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with NAVAMEDIC dropping 8.11% to €34.00 on Friday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI rose 0.43% to €1,260.92, following the last session’s downward trend on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.73.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 19.65. Meaning, the purchaser of the share is investing kr19.65 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.97%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 93.3%, now sitting on 440.93M for the twelve trailing months.
More news about NAVAMEDIC.
4. ENVIPCO (ENVI.AS)
-5.83% Price Change
Envipco Holding N.V., together with its subsidiaries, designs, develops, manufactures, and sells or leases reverse vending machines (RVM) for the collection and processing of used beverage containers primarily in the Netherlands, North America, and Europe. The company provides technical support, RVM maintenance, and accounting services to the retail stores, bottlers, and distributors for containers redeemed through its machines. It also offers deposit, handling fees, scrap reconciliations, commodity brokerage, clearing house functions, and accounting services. In addition, the company provides materials handling services primarily in the northeastern part of the United States. Envipco Holding N.V. was incorporated in 1998 and is headquartered in Amersfoort, the Netherlands.
AEX-Index ended the session with ENVIPCO dropping 5.83% to €2.26 on Friday while AEX-Index fell 1.62% to €765.16.
Earnings Per Share
As for profitability, ENVIPCO has a trailing twelve months EPS of €-0.09.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -14.3%.
Volume
Today’s last reported volume for ENVIPCO is 17510 which is 332.23% above its average volume of 4051.
Sales Growth
ENVIPCO’s sales growth is negative 4.2% for the present quarter and negative 13.5% for the next.
Yearly Top and Bottom Value
ENVIPCO’s stock is valued at €2.26 at 22:40 EST, way below its 52-week high of €3.65 and higher than its 52-week low of €2.20.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 93.1% and a negative 350%, respectively.
More news about ENVIPCO.
5. XILAM ANIMATION (XIL.PA)
-5.18% Price Change
Xilam Animation operates as an audiovisual production company in France and internationally. The company creates, produces, and distributes original programs for children and adults. It also broadcasts content on television; subscription video on demand streaming platforms, including Netflix, Disney +, Amazon, and NBC Universal; and advertising video on demand streaming platforms, such as YouTube, Facebook, Rakuten TV, Tubi, and Pluto TV. In addition, the company produces animated, short, and feature films. It owns the Oggy, Cockroaches, Zig & Sharko, Chicky, Oggy Oggy, Oggy Next Gen, Les Contes de Lupin, Moka, Mr Magoo, Trico, and J'ai Perdu Mon Corps brands. The company was incorporated in 1999 and is headquartered in Paris, France.
CAC 40 ended the session with XILAM ANIMATION falling 5.18% to €23.80 on Friday while CAC 40 dropped 1.26% to €7,340.19.
Earnings Per Share
As for profitability, XILAM ANIMATION has a trailing twelve months EPS of €0.3.
PE Ratio
XILAM ANIMATION has a trailing twelve months price to earnings ratio of 79.33. Meaning, the purchaser of the share is investing €79.33 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.89%.
Volume
Today’s last reported volume for XILAM ANIMATION is 2691 which is 43.9% above its average volume of 1870.
Volatility
XILAM ANIMATION’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.82%, a negative 0.19%, and a positive 1.45%.
XILAM ANIMATION’s highest amplitude of average volatility was 0.82% (last week), 0.90% (last month), and 1.45% (last quarter).
Revenue Growth
Year-on-year quarterly revenue growth grew by 30.5%, now sitting on 39.86M for the twelve trailing months.
More news about XILAM ANIMATION.
6. GC RIEBER SHIPPING (RISH.OL)
-5.04% Price Change
GC Rieber Shipping ASA operates as a ship-owning project house with a focus on developing maritime projects in Norway and internationally. The company was incorporated in 2005 and is headquartered in Bergen, Norway. GC Rieber Shipping ASA is a subsidiary of GC Rieber AS.
Oslo Børs Benchmark Index_GI ended the session with GC RIEBER SHIPPING sliding 5.04% to €18.85 on Friday while Oslo Børs Benchmark Index_GI rose 0.43% to €1,260.92.
Earnings Per Share
As for profitability, GC RIEBER SHIPPING has a trailing twelve months EPS of kr-0.41.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.94%.
Volatility
GC RIEBER SHIPPING’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.79%, a positive 0.51%, and a positive 2.45%.
GC RIEBER SHIPPING’s highest amplitude of average volatility was 3.79% (last week), 2.77% (last month), and 2.45% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GC RIEBER SHIPPING’s stock is considered to be overbought (>=80).
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Apr 26, 2023, the estimated forward annual dividend rate is 0.25 and the estimated forward annual dividend yield is 1.06%.
More news about GC RIEBER SHIPPING.
7. FOUNTAIN (FOU.BR)
-5% Price Change
Fountain S.A. engages in the sale, rental, and provision of machines for cold and hot drinks made from freeze-dried or grain products in Europe. It provides coffee and cartridge machines, and other beverages machines. The company offers its products through independent distributors. Fountain S.A. was founded in 1972 and is based in Braine-l'Alleud, Belgium.
BEL 20 ended the session with FOUNTAIN sliding 5% to €1.14 on Friday, after three successive sessions in a row of losses. BEL 20 dropped 0.91% to €3,684.94, after two consecutive sessions in a row of gains, on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, FOUNTAIN has a trailing twelve months EPS of €-0.15.
Volatility
FOUNTAIN’s last week, last month’s, and last quarter’s current intraday variation average was a negative 4.17%, a positive 2.01%, and a positive 7.16%.
FOUNTAIN’s highest amplitude of average volatility was 4.17% (last week), 3.57% (last month), and 7.16% (last quarter).
Volume
Today’s last reported volume for FOUNTAIN is 1000 which is 25.31% above its average volume of 798.
More news about FOUNTAIN.
8. NEXT BIOMETRICS GP (NEXT.OL)
-4.81% Price Change
NEXT Biometrics Group ASA, through its subsidiaries, engages in the research, development, manufacture, and commercialization of fingerprint technology and products in Asia. The company offers fingerprint sensor modules and readers, flexible biometric subassemblies, and face recognition software, as well as software and hardware development kits for USB and SPI modules. Its products are used in point of sales terminals, smart card, government ID, access control, internet of things, and notebook applications. The company sells its sensors to distributors of electronic components. NEXT Biometrics Group ASA was incorporated in 2001 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with NEXT BIOMETRICS GP dropping 4.81% to €5.54 on Friday, after two successive sessions in a row of losses. Oslo Børs Benchmark Index_GI jumped 0.43% to €1,260.92, following the last session’s downward trend on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, NEXT BIOMETRICS GP has a trailing twelve months EPS of kr-0.51.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -45.11%.
More news about NEXT BIOMETRICS GP.
9. DASSAULT AVIATION (AM.PA)
-4.77% Price Change
Dassault Aviation Société anonyme designs and builds military aircraft, business jets, and space systems in France, the Americas, and internationally. It offers Rafale, a multirole fighter aircraft; nEUROn, an unmanned combat air vehicle; and Falcon aircraft for maritime surveillance, intelligence, and medical evacuation missions. The company operates a fleet of 2,100 Falcon jets and 1,000 military aircraft. In addition, it provides aviation maintenance and training services; repairs and maintains landing gears and flight controls; overhauls and repairs civil aviation equipment; leases and manages Falcon aircraft as part of public passenger transport activity; and designs, produces, and distributes simulation tools. The company was founded in 1916 and is headquartered in Paris, France. Dassault Aviation Société anonyme operates as a subsidiary of Groupe Industriel Marcel Dassault S.A.
CAC 40 ended the session with DASSAULT AVIATION dropping 4.77% to €171.80 on Friday, after five consecutive sessions in a row of gains. CAC 40 slid 1.26% to €7,340.19, after two consecutive sessions in a row of gains, on what was an all-around negative trend trading session today.
Earnings Per Share
As for profitability, DASSAULT AVIATION has a trailing twelve months EPS of €8.62.
PE Ratio
DASSAULT AVIATION has a trailing twelve months price to earnings ratio of 19.93. Meaning, the purchaser of the share is investing €19.93 for every euro of annual earnings.
Volatility
DASSAULT AVIATION’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.46%, a negative 0.01%, and a positive 1.60%.
DASSAULT AVIATION’s highest amplitude of average volatility was 0.46% (last week), 1.46% (last month), and 1.60% (last quarter).
More news about DASSAULT AVIATION.
10. PAREF (PAR.PA)
-4.46% Price Change
Paref SA owns and manages business real estate located primarily in the Paris region. The company manages and leases real estate, offices and commercial spaces, and residences. The company also provides real estate agency services. The company was founded in 1997 and is based in Paris, France.
CAC 40 ended the session with PAREF sliding 4.46% to €53.50 on Friday, following the last session’s upward trend. CAC 40 fell 1.26% to €7,340.19, after two successive sessions in a row of gains, on what was an all-around negative trend exchanging session today.
Earnings Per Share
As for profitability, PAREF has a trailing twelve months EPS of €2.67.
PE Ratio
PAREF has a trailing twelve months price to earnings ratio of 20.04. Meaning, the purchaser of the share is investing €20.04 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.78%.
More news about PAREF.
Stay up to date with our winners and losers daily report
